Tianda Pharmaceuticals Limited (SEHK:455) entered into an equity transfer agreement to acquire 45% stake in Yunnan Mengsheng Pharmaceutical Co., Ltd from Yunnan Linuo Biotechnology Co., Ltd. for HKD 23.5 million on August 1, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.24 HKD | -5.88% | +4.35% | +10.09% |
Jun. 07 | Tianda Pharmaceuticals Limited Approves Final Dividend | CI |
May. 16 | Tianda Pharmaceuticals Unit Gets Registration Go-Ahead for Acute Coronary Drug from Chinese Regulator | MT |
1st Jan change | Capi. | |
---|---|---|
+10.09% | 66.06M | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B |
- Stock Market
- Equities
- 455 Stock
- News Tianda Pharmaceuticals Limited
- Tianda Pharmaceuticals Limited entered into an equity transfer agreement to acquire 45% stake in Yunnan Mengsheng Pharmaceutical Co., Ltd from Yunnan Linuo Biotechnology Co., Ltd. for HKD 23.5 million.